Edition:
India

Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

7.67USD
22 Jun 2018
Change (% chg)

$0.18 (+2.40%)
Prev Close
$7.49
Open
$7.50
Day's High
$7.68
Day's Low
$7.38
Volume
29,612
Avg. Vol
4,385
52-wk High
$11.34
52-wk Low
$6.19

Select another date:

Mon, Apr 23 2018

BRIEF-Oramed Initiates Its 90-Day Pivotal Dose-Ranging Clinical Study For Oral Insulin

* ORAMED INITIATES ITS 90-DAY PIVOTAL DOSE-RANGING CLINICAL STUDY FOR ORAL INSULIN Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Oramed Pharmaceuticals' Unit Enters Clinical Research Organization Services Agreement With Integrium

* SAYS ON FEB 14, A UNIT ENTERED CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT WITH INTEGRIUM EFFECTIVE AS OF NOV 1, 2017‍​

Select another date: